NancyS.ScherMD

Oncology • Washington, DC

Breast Cancer, Hematologic Oncology

Physician

Join to view full profile

Dr. Scher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Scher's full profile

Already have an account?

Office
50 Irving St Nw
Medical Service/Hematology
Washington, DC 20422
Phone+1 202-745-8134
Is this information wrong?

Education & Training

University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1976 - 1977
NYU Grossman School of MedicineResidency, Internal Medicine, 1971 - 1976
Perelman School of Medicine at the University of PennsylvaniaClass of 1971

Certifications & Licensure

WV State Medical License 1978 - 2025
NY State Medical License 1972 - 2019
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

44 citations
FDA Approval Summary: Pertuzumab for Adjuvant Treatment of HER2-Positive Early Breast Cancer
Lynn J. Howie, Nancy S. Scher, Laleh Amiri-Kordestani, Lijun Zhang, Bellinda L. King-Kallimanis, Yasmin Choudhry, Jason Schroeder, Kirsten B. Goldberg, Paul G. Kluetz,...> ;Clinical Cancer Research. 2019 May 15
78 citations
First FDA Approval of Dual Anti-HER2 Regimen: Pertuzumab in Combination with Trastuzumab and Docetaxel for HER2-positive Metastatic Breast Cancer
Gideon M. Blumenthal, Nancy S. Scher, Patricia Cortazar, Somesh Chattopadhyay, Shenghui Tang, Pengfei Song, Qi Liu, Kimberly Ringgold, Anne M. Pilaro, Amy Tilley, Kath...> ;Clinical Cancer Research. 2013 Sep 15
76 citations
End points to establish the efficacy of new agents in the treatment of acute leukemia
Frederick R. Appelbaum, Daniel Rosenblum, Robert J. Arceci, William L. Carroll, Philip P. Breitfeld, Stephen J. Forman, Richard A. Larson, Stephanie J. Lee, Sharon B. ...> ;Blood. 2007 Mar 1
145 citations
Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases
Amna Ibrahim, Nancy S. Scher, Grant R. Williams, Rajeshwari Sridhara, Ning Li, Gang Chen, John K. Leighton, Brian Booth, Jogarao V. S. Gobburu, Atiqur Rahman, Yung Hsi...> ;Clinical Cancer Research. 2003 Jul 1
41 citations
U.S. Food and Drug Administration Drug Approval Summaries: Imatinib Mesylate, Mesna Tablets, and Zoledronic Acid
Martin H. Cohen, Ramzi Dagher, Donna Griebel, Amna Ibrahim, Alison Martin, Nancy S. Scher, Gerald H. Sokol, Grant A. Williams, Richard Pazdur> ;The Oncologist. 2002 Oct 1
3 citations
Protein kinases in chronic lymphocytic leukemia.
Edward T. Samuel, Chih-hua Chung, Nancy Scher, Barry P. Rosenzweig, Robert Silber> ;Blood. 1980 Apr 1
Cyclic adenosine 3'':5''-monophosphate phosphodiesterase activity in normal and chronic lymphocytic leukemia lymphocytes.
Scher, N. S., Quagliata, F., Malathi, V. G., Faig, D., Melton, R. A., Silber, R.> ;Cancer Res. 1976 Nov
Malignant melanoma in West Virginia.
Scher, K. S., Scher, N. S., O'Connor, D. S.> ;South Med J. 1981 Jan
Join now to see all

NancyS.ScherMD

Dr. Scher is on Doximity

Education & Training

Certifications & Licensure

Publications & Presentations

Viewing the full profile is available to verified healthcare professionals only.